Wernicke‑Korsakoff‑like Syndrome in Cancer Patients

Overview

Wernicke‑Korsakoff‑like syndrome (WKLS) refers to a spectrum of neuro‑cognitive disturbances that resemble classic Wernicke’s encephalopathy and Korsakoff’s syndrome but occur in patients who do not have the typical alcohol‑related risk profile. In oncology, WKLS most often results from severe thiamine (vitamin B1) deficiency caused by malnutrition, high‑output metabolic demands, or chemotherapy‑induced gastrointestinal toxicity.

• Who it affects: Adults undergoing treatment for solid tumors (especially gastrointestinal and head‑and‑neck cancers) or hematologic malignancies, particularly when there is prolonged nausea, vomiting, or poor oral intake.
• Prevalence: Exact rates are uncertain because WKLS is under‑recognized, but retrospective studies suggest 2–5 % of hospitalized oncology patients develop clinically significant thiamine deficiency, and up to 10 % of those exhibit neuro‑cognitive signs consistent with WKLS (Sullivan et al., 2021; WHO, 2022).
• Why it matters: Untreated WKLS can lead to persistent memory loss, gait instability, and permanent neurological disability, worsening quality of life and complicating cancer care.

Symptoms

Symptoms may appear acutely (classic Wernicke’s encephalopathy) or evolve over weeks (Korsakoff‑type amnesia). In cancer patients, the presentation can be atypical because of overlapping treatment side‑effects.

Classic triad of Wernicke’s encephalopathy

• Ocular abnormalities: Nystagmus (rapid eye movements), gaze palsy, or double vision.
• Ataxia: Unsteady gait, difficulty standing, or a “staggering” gait; patients may be unable to heel‑toe walk.
• Confusion/altered mental status: Disorientation, inattentiveness, or profound drowsiness.

Korsakoff‑type features (usually develop days–weeks after the acute phase)

• Anterograde amnesia: Inability to form new memories; patients repeat questions.
• Retrograde amnesia: Gaps in recalling events that occurred before the illness.
• Confabulation: Fabricated or distorted memories presented as facts.
• Executive dysfunction: Poor planning, difficulty with problem‑solving, and impaired judgment.

Other possible manifestations in oncology patients

• Peripheral neuropathy (numbness, tingling)
• Hypotension or orthostatic dizziness
• Severe fatigue that does not improve with rest
• Rapid weight loss and muscle wasting

Causes and Risk Factors

In cancer patients, WKLS is almost always linked to thiamine deficiency, but the pathways leading to deficiency are multifactorial.

Primary causes

• Inadequate intake: Persistent nausea, vomiting, mucositis, dysphagia, or anorexia limit oral nutrition.
• Increased requirements: Tumor metabolism and systemic inflammation raise the body’s demand for thiamine.
• Malabsorption: Radiation or surgical resections of the small intestine diminish nutrient absorption.
• Parenteral nutrition without thiamine supplementation: Some total‑parenteral nutrition (TPN) regimens omit adequate thiamine.
• Alcohol use: Though less common in this group, any concurrent alcohol consumption worsens depletion.
• Certain chemotherapeutics: Fluorouracil, cisplatin, and high‑dose cytarabine can cause severe gastrointestinal toxicity that precipitates deficiency.

Risk‑factor summary

Diagnosis

Diagnosis is clinical but should be supported by laboratory and imaging studies to rule out other causes of encephalopathy.

Clinical assessment

• Detailed history focusing on nutrition, vomiting, chemotherapy, and alcohol use.
• Neurological exam for ocular signs, gait, and mental status.

Laboratory tests

• Serum thiamine level: Measured by high‑performance liquid chromatography; levels < 70 nmol/L are considered deficient.
• Red blood cell (RBC) thiamine pyrophosphate (TPP) assay: More reliable for chronic deficiency.
• Basic metabolic panel, liver function tests, and ammonia to exclude hepatic encephalopathy.
• Complete blood count – assess for anemia or infection.

Imaging

• MRI brain: Typical findings include symmetric hyperintensities on T2/FLAIR in the thalami, mammillary bodies, periaqueductal gray, and cerebellar vermis. These are not specific but support the diagnosis when correlated with clinical signs.
• CT is less sensitive but useful in emergent settings to rule out hemorrhage or mass effect.

Diagnostic criteria (modified for oncology)

1. Presence of at least two of the three classic Wernicke signs **plus** a known risk factor (e.g., prolonged vomiting).
2. Or, one classic sign **plus** confirmed low thiamine level.
3. Exclusion of alternative causes (e.g., brain metastases, medication toxicity).

Treatment Options

Prompt thiamine repletion is the cornerstone of therapy. Delay > 48 h reduces the chance of full neurologic recovery.

Pharmacologic therapy

• Thiamine (vitamin B1) IV:
  • Loading dose: 200 mg IV bolus three times daily for 2–3 days.
  • Maintenance: 100 mg IV or IM once daily for at least 5 days, then transition to oral 100 mg daily for 2–4 weeks.
• Adjunct vitamins: Folate, pyridoxine (B6), and cobalamin (B12) are often co‑administered because deficiencies commonly coexist.
• Electrolyte correction: Replenish Mg²⁺ and K⁺, as hypomagnesemia hampers thiamine utilization.

Procedural and supportive measures

•  **Nutritional support** – Initiate or adjust enteral feeding; if not feasible, use TPN with full vitamin supplementation.
•  **Physical therapy** – Early gait and balance training to reduce fall risk.
•  **Occupational therapy** – Cognitive rehabilitation strategies for memory deficits.
•  **Psychiatric care** – Address confabulation, depression, or anxiety that may accompany the syndrome.

Lifestyle / supportive recommendations

• High‑protein, thiamine‑rich diet (whole grains, pork, beans, nuts, seeds).
• Avoid high‑dose diuretics without magnesium replacement.
• Hydration: maintain adequate fluids to support renal clearance of excess metabolites.

Living with Wernicke‑Korsakoff‑like Syndrome in Cancer Patients

Managing WKLS alongside cancer treatment requires coordinated care.

Daily management tips

• Medication adherence: Keep a pillbox or set alarms for thiamine and other supplements.
• Nutrition tracking: Use a food diary; involve a dietitian to ensure ≥ 1.2 mg thiamine per day (the Recommended Dietary Allowance for adults).
• Safe environment: Install grab bars, non‑slip mats, and good lighting to prevent falls.
• Cognitive aids: Use notebooks, smartphone reminders, and “memory notebooks” for daily tasks.
• Support network: Engage family members or caregivers in monitoring for new confusion or falls.
• Follow‑up schedule: Re‑evaluate neurologic status 1 week after initiating therapy, then monthly until stable.

Interaction with cancer treatment

Thiamine repletion does not interfere with chemotherapy, but physicians should be aware that:

• Severe neurologic symptoms may be mistaken for chemotherapy‑induced neuropathy.
• Patients with ongoing WKLS may need dose adjustments or temporary holds on neurotoxic agents (e.g., high‑dose vincristine).

Prevention

Because WKLS is largely preventable, proactive steps are essential, especially for high‑risk oncology patients.

• Screening: Assess thiamine status (serum or RBC) in any patient with > 7 days of persistent vomiting, diarrhea, or oral intake < 50 % of estimated needs.
• Prophylactic supplementation: For patients receiving TPN or prolonged nil‑by‑mouth status, add 100 mg thiamine daily to the regimen.
• Early nutrition consult: Involve a clinical nutritionist at diagnosis of high‑risk cancers.
• Educate patients & families: Provide written materials on signs of thiamine deficiency.
• Monitor electrolytes: Correct magnesium and potassium deficits promptly to support thiamine metabolism.

Complications

If untreated or delayed, WKLS can lead to serious sequelae:

• Permanent Korsakoff amnesia – irreversible loss of new‑memory formation.
• Falls and related fractures due to gait ataxia.
• Delirium or coma, especially when combined with other metabolic derangements.
• Prolonged hospital stay, increased healthcare costs, and reduced ability to tolerate cancer therapy.
• Psychiatric complications – depression, anxiety, and social isolation.

When to Seek Emergency Care

References

• Sullivan, D. et al. “Thiamine deficiency and Wernicke‑Korsakoff syndrome in oncology patients.” Cancer Medicine, 2021;10(14):2501‑2510.
• Mayo Clinic. “Wernicke‑Korsakoff syndrome.” Updated 2023. https://www.mayoclinic.org
• World Health Organization. “Guidelines for vitamin supplementation in clinical nutrition.” 2022.
• Cleveland Clinic. “Thiamine deficiency.” Accessed May 2024. https://my.clevelandclinic.org
• National Institutes of Health. “Thiamine (Vitamin B1) Fact Sheet for Health Professionals.” 2023.
• CDC. “Cancer‑related malnutrition and micronutrient deficiencies.” 2022.